The reproducibility of an advanced single voxel MRS protocol was tested in a clinical cohort and control subjects at 3T in a multi-site setting. A standardized MRS protocol was implemented on two MR system vendors (Siemens, Philips) over three sites. This protocol utilized automated voxel placement and an sLASER pulse sequence with identical radiofrequency waveforms, pulse durations, interpulse delays and gradient spoilers. Spectral quality, metabolite concentrations and test-retest reproducibility results from three voxels are reported from both the healthy control group and subjects with genetically-confirmed spinocerebellar ataxia type 3 (SCA3), a hereditary movement disorder.
This abstract and the presentation materials are available to members only; a login is required.